BRIGHT MINDS BIOSCIENCES INC. (DRUG) research

BRIGHT MINDS BIOSCIENCES INC.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$59.46
As of

BRIGHT MINDS BIOSCIENCES INC. (DRUG): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-08-17.

As of . Source: SEC EDGAR filings for DRUG. Method and limitations.

SHARE THIS CARD

Share the DRUG intelligence card

A branded snapshot of DRUG: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion DRUG intelligence card preview
Post to X
LIVE TERMINAL

See DRUG live in the terminal

Track DRUG's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live DRUG terminal, free

Active signals for DRUG

FREE, NO ACCOUNT

Every signal on DRUG, as it fires

You are seeing 5 of 15 signals recorded on DRUG since 2026-08-16.

The five above landed across 2 days. The other 10 were recorded on 1 other days. 11 of the 15 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in DRUG (2026Q2)

Manager / securityMarket value% portfolioQoQ
Point72 Asset Management, L.P.CUSIP 10919W405 · 2026Q2$23M0.03%,
MILLENNIUM MANAGEMENT LLCCUSIP 10919W405 · 2026Q2$4.7M0.00%,
CITADEL ADVISORS LLCCUSIP 10919W405 · 2026Q2$4.7M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 10919W405 · 2026Q2$674K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, DRUG

Related tickers

See more DRUG signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to DRUGand get the insider, 13F, options, and confluence read in one view.

Open the live DRUG terminal, free